An NIH-supported study on vitamin E tocotrienol supplementation has found a potential brain-protective effect from the nutrient following ischemic stroke.
An NIH-supported study on vitamin E tocotrienol supplementation has found a potential brain-protective effect from the nutrient following ischemic stroke.
Published in the Journal of Cerebral Blood Flow and Metabolism, the study enlisted 20 dogs to 400 mg of full spectrum palm tocotrienol complex (Tocomin Suprabio) or placebo daily for 10 weeks. Stroke was induced 12 hours after final supplementation.
Compared to placebo, dogs supplementing with tocotrienols had significantly less volume on stroke-induced lesions. Overall size of lesions after 1 and 24 hours was reduced by 60% and 80% respectively, compared to placebo. Tocotrienol consumption appeared to prevent loss of white matter fiber tract connectivity while also increasing blood circulation through arteries in the brain that suffered stroke.
“We are particularly pleased to see that tocotrienols helped recovery from stroke by restoring blood flow through inducing the generation of new brain arteries that bypass stroke-affected areas,” said WH Leong, vice president of Carotech Inc., which supplied the tocotrienol.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.